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Pyrazolo[3,4-d]pyrimidineAbstract A simple, green and environmentally benign procedure was developed for the one pot
synthesis of 3-methyl-1,4-diphenyl-1,4,5,7-tetrahydro-pyrazolo[3,4-d]pyrimidine-6-one/thiones
using catalytic amount of phthalimide-N-sulfonic acid (PISA) in 1-butyl-3-methylimidazolium bro-
mide ([Bmim][Br]) ionic liquid via the three-component reaction of 1-phenyl-3-methyl-1H-pyrazole-
5(4H)-one, aromatic aldehyde and urea/thiourea. [Bmim][Br] as reaction media offers several
advantages including non-toxic, non-corrosive, shorter reaction times, high yield of the products,
mild reaction conditions as well as simple experimental and isolation procedures.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The elimination of volatile organic solvents in organic synthe-
sis is the most important goal in green chemistry. Ionic liquids(ILs) are an excellent alternative to substitute volatile organic
solvents in more environmentally friendly technologies. ILs are
growingly popular because they have been recognized as
important novel solvents showing specific properties including
high heat capacity, high density, extremely low volatility, non-
flammability, high thermal stability, and wide temperature
range for liquid state. They are also known as environmentally
benign catalysts and much attention has currently been
focused on organic reactions in the presence of these com-
pounds as catalysts or solvents [1–5].
The development of simple routes toward making widely
used organic compounds from readily available reagents andsis of 3-
l Society
2 S.P.N. Sudhan et al.compounds is one of the major tasks in organic synthesis.
Multi-component condensation reactions (MCRs) occupy an
advantageous position among other reactions, because of high
atom economy, high yields, convergent character and simplic-
ity of procedures [6,7]. Therefore, the discovery and develop-
ment of novel MCRs is one of the goals of chemistry
research groups.
Pyrazoles are a novel class of heterocyclic compounds pos-
sessing a wide variety of applications in the pharmaceutical
industries [8]. Derivatives of pyrazoles are found to show good
antibacterial [9], anti-inflammatory [10], antitumor and anti-
HCV [11], anticancer, radioprotective [12] and anti-
convulsant activity [13]. The structural diversity and biological
importance of pyrimidines have made them attractive targets
for synthesis over many years [14–16]. Fused pyrimidine
derivatives have shown diverse biological activities. Among
them, pyrazolo[3,4-d]pyrimidines as purine analogs have
attracted considerable interest due to their remarkable phar-
macological properties [17]. Pyrazolo[3,4-d]pyrimidines exhibit
antimicrobial activity [18], antiviral activity [19], anti-tumor
activity [20], adenosine A2A receptor antagonists [21], reactive
oxygen species in human breast adenocarcinoma cells [22],
anti-proliferative activity [23], antitumor and anti-leukemia
activity [24], anti-mycobacterial [25] and CK1 inhibitors [26].
During the last few years, synthesis of pyrazolo[3,4-d]
pyrimidines has received great interest. A recent literature
survey indicated that the synthesis of the pyrazolo[3,4-d]pyrim-
idine derivatives has been conducted using molecular iodine
[27], heteropolyacids [28,29], microwave-assisted reaction
[30,31] and Vilsmeier-type reagents [32]. A series of
3-amino-6-aryl-2-phenylpyrazolo[3,4-d]pyrimidine derivatives
were prepared through an efficient and environmentally
friendly reaction between 4-amino-6-aryl-2-phenylpyrimidine-
5-carbonitrile derivatives and hydrazine hydrate [33]. A variety
of pyrazolo[3,4-d]pyrimidine-6(7H)-thione derivatives were
easily synthesized in the presence of catalytic amount of
p-toluene sulfonic acid (p-TSA) in 1-butyl-3-
methylimidazolium bromide ionic liquid [34]. The reaction of
phenylisothiocyanate, 5-methyl-1H-pyrazol-3-amine, and alde-
hyde was used for the synthesis of pyrazolo[3,4-d]pyrimidine-6
(7H)-thiones. In the presence of p-TSA under solvent-free con-
ditions, the yield of the final product was not high, mainly
because the reaction mixture could not be stirred well. In order
to improve the yield, the ionic liquid [Bmim][Br] was used as a
solvent. The results indicated that the reaction proceeded effi-Scheme 1 Synthesis of various 3-methyl-1,4-diphenyl-1,4
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was obtained in excellent yield. However, the major drawback
of these procedures includes long reaction times, low to mod-
erate yields, large excess of a strong Brønsted acid and limited
number of reactants and partial structural diversity of prod-
ucts. Consequently, designing a new synthetic pathway to
obtain these structurally complex heterocycles is of great inter-
est in the modern drug discovery.
In recent years phthalimide-N-sulfonic acid (PISA) has
drawn much interest in different organic reactions due to its
experimental simplicity. PISA has been used as a catalyst for
the solvent-free synthesis of 5-alkenyl-2,2-butylidene-1,3-diox
ane-4,6-diones under ultrasonic irradiation [35], synthesis of
3,4-dihydropyrimidin-5(1H)-ones/thiones under solvent-free
conditions [36] and for the solvent-free synthesis of 2-(2-oxo-
2H-chromen-3-yl)-4-aryl-indeno[1,2-b]pyridine-5-ones [37].
In continuation of our previous research in heterocyclic
synthesis [38–42], herein, we wish to report a novel and straight-
forward synthetic pathway to access fused 3-methyl-1,4-
diphenyl-1,4,5,7-tetrahydro-pyrazolo[3,4-d]pyrimidine-6-ones/
thiones by the three-component reaction of 1-phenyl-3-methyl-
1H-pyrazole-5(4H)-one, aromatic aldehyde and urea/thiourea
in the presence of catalytic amount of PISA in [Bmim][Br] ionic
liquid at 80 C (Scheme 1).
Recently, one pot synthesis of 7-phenyl-1,4,6,7-tetrahydro
thiazolo[5,4-d]pyrimidine-2,5-diones via a multicomponent
reaction between thiazolidine-2,4-dione, aromatic aldehyde
and urea analogs is described. The ionic liquid has been used
as a solvent as well as catalyst for this reaction [43].
2. Experimental
2.1. Chemicals and apparatus
Chemicals were purchased from Merck, Fluka and Aldrich
Chemical Companies. All yields refer to isolated products
unless otherwise stated. 1H NMR (500 MHz) and 13C NMR
(125 MHz) spectra were obtained using Bruker DRX-500
Avance at ambient temperature, using TMS as internal stan-
dard. FT-IR spectra were obtained as KBr disks on Shimadzu
spectrometer. Mass spectra were determined on a Varion -
Saturn 2000 GC/MS instrument. Elemental analysis was mea-
sured by means of Perkin Elmer 2400 CHN elemental analyzer
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Ionic liquid 1-butyl-3-methylimidazolium bromide 32.2. Preparation of phthalimide-N-sulfonic acid
Phthalimide-N-sulfonic acid (PISA) as a stable reagent is easily
prepared [36] as reported previously by the reaction of potas-
sium phthalimide with chlorosulfonic acid (Scheme 2).
2.3. General procedure for the synthesis of 3-methyl-1,4-
diphenyl-1,4,5,7-tetrahydro-pyrazolo[3,4-d]pyrimidin-6-one/
thiones (4a-n)
A mixture of 1-phenyl-3-methyl-1H-pyrazole-5(4H)-one 1
(1 mmol), urea/thiourea 3 (1.2 mmol) was stirred for 5 min at
80 C. Then, aldehyde 2 (1 mmol) and PISA (0.1 mmol),
[Bmim][Br] (0.4 g) were added and the mixture was heated at
80 C for 0.8–1.0 h. After completion of the reaction (moni-
tored by TLC, eluent: n-hexane/ethyl acetate, 2:1), the mixture
was cooled to room temperature, washed with water (25 mL)
and the residue was purified by recrystallization from EtOH
to afford the pure products. If necessary, the product was puri-
fied by silica gel column chromatography (eluent: n-hexane/
ethyl acetate, 3:1). The PISA used for the transformation
was recovered and used for further reactions.
2.4. Spectral data for the synthesized compounds (4a-n)
2.4.1. 3-Methyl-1,4-diphenyl-1,4,5,7-tetrahydro-pyrazolo[3,4-
d]pyrimidin-6-one (4a)
IR (KBr): 3344, 3206, 2972, 1671, 1566, 1446, 794 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.22 (s, 3H, CH3-3), 5.52 (s,
1H, CH-4), 6.81–7.15 (m, 5H, Ar–H), 7.35–7.52 (m, 5H, Ar–
H), 8.17 (s, 1H, NH-5), 9.26 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 11.9, 43.6, 104.7, 118.2, 126.1,
126.4, 127.5, 128.0, 128.4, 129.5, 138.9, 143.0, 148.9, 151.1,
167.0 ppm; MS (ESI): m/z 305 (M+H)+. Anal. Calcd. for
C18H16N4O (%): C, 71.05; H, 5.26; N, 18.42. Found: C,
71.01; H, 5.22; N, 18.38.
2.4.2. 3-Methyl-1,4-diphenyl-1,4,5,7-tetrahydro-pyrazolo[3,4-
d]pyrimidin-6-thione (4b)
IR (KBr): 3353, 3192, 2970, 1571, 1363, 1250, 778 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.28 (s, 3H, CH3-3), 5.50 (s,
1H, CH-4), 6.79–7.14 (m, 5H, Ar–H), 7.30–7.49 (m, 5H, Ar–
H), 8.14 (s, 1H, NH-5), 9.27 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 11.7, 44.1, 105.0, 118.8, 126.3,
126.6, 127.7, 128.2, 128.6, 128.9, 139.4, 143.1, 148.7, 150.7,
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2.4.3. 3-Methyl-1-phenyl-4-(4-chlorophenyl)-1,4,5,7-
tetrahydro-pyrazolo[3,4-d]pyrimidin-6-one (4c)
IR (KBr): 3353, 3216, 2979, 1668, 1577, 1448, 788 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.18 (s, 3H, CH3-3), 5.48 (s,
1H, CH-4), 6.84–7.11 (m, 5H, Ar–H), 7.29 (d, 2H,
J= 8.4 Hz, ArH), 7.59 (d, 2H, J= 8.4 Hz, ArH), 8.12
(s,1H, NH-5), 9.21 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 12.5, 43.7, 105.3, 118.6, 126.2,
126.7, 127.3, 128.3, 128.8, 129.3, 139.5, 142.5, 149.0, 150.5,
166.5 ppm; MS (ESI): m/z 339 (M+ H)+. Anal. Calcd. for
C18H15ClN4O (%): C, 63.82; H, 4.43; N, 16.55. Found: C,
63.71; H, 4.33; N, 16.56.
2.4.4. 3-Methyl-1-phenyl-4-(4-chlorophenyl)-1,4,5,7-
tetrahydro-pyrazolo[3,4-d]pyrimidin-6-thione (4d)
IR (KBr): 3349, 3194, 2978, 1575, 1360, 1243, 774 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.20 (s, 3H, CH3-3), 5.46 (s,
1H, CH-4), 6.85–7.09 (m, 5H, Ar–H), 7.34 (d, 2H,
J= 8.2 Hz, ArH), 7.54 (d, 2H, J= 8.2 Hz, ArH), 8.19
(s,1H, NH-5), 9.22 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 12.0, 44.2, 104.8, 118.0, 126.4,
126.8, 127.4, 128.4, 128.7, 129.2, 139.3, 142.7, 149.1, 151.0,
167.1 ppm; MS (ESI): m/z 355 (M+ H)+. Anal. Calcd. for
C18H15ClN4S (%): C, 60.94; H, 4.23; N, 15.80. Found: C,
60.88; H, 4.17; N, 15.77.
2.4.5. 3-Methyl-1-phenyl-4-(4-fluorophenyl)-1,4,5,7-tetrahydro-
pyrazolo[3,4-d]pyrimidin-6-one (4e)
IR (KBr): 3357, 3205, 2981, 1665, 1569, 1449, 783 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.19 (s, 3H, CH3-3), 5.51 (s,
1H, CH-4), 6.88–7.08 (m, 5H, Ar–H), 7.36 (d, 2H,
J= 8.2 Hz, ArH), 7.55 (d, 2H, J= 8.2 Hz, ArH), 8.15
(s,1H, NH-5), 9.21 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 12.1, 43.8, 104.9, 117.9, 126.2,
126.6, 127.5, 128.5, 128.9, 129.4, 138.8, 143.2, 148.8, 151.3,
166.9 ppm; MS (ESI): m/z 323 (M+ H)+. Anal. Calcd. for
C18H15FN4O (%): C, 67.01; H, 4.66; N, 17.39. Found: C,
66.94; H, 4.60; N, 17.31.
2.4.6. 3-Methyl-1-phenyl-4-(4-fluorophenyl)-1,4,5,7-tetrahydro-
pyrazolo[3,4-d]pyrimidin-6-thione (4f)
IR (KBr): 3361, 3197, 2975, 1569, 1371, 1248, 773 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.24 (s, 3H, CH3-3), 5.56 (s,limidazolium bromide: A green reaction media for the eﬃcient synthesis of 3-
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ArH), 7.50 (d, 2H, J= 8.0 Hz, ArH), 8.21 (s,1H, NH-5), 9.25
(s, 1H, NH-7) ppm; 13C NMR (125 MHz, DMSO-d6) d: 11.8,
43.9, 105.2, 118.1, 126.4, 126.7, 127.7, 128.0, 128.4, 128.7,
138.8, 142.7, 148.7, 150.5, 166.8 ppm; MS (ESI): m/z 339 (M
+H)+. Anal. Calcd. for C18H15FN4S (%): C, 54.15; H,
3.76; N, 14.00. Found: C, 54.10; H, 3.72; N, 13.92.
2.4.7. 3-Methyl-1-phenyl-4-(4-nitrophenyl)-1,4,5,7-tetrahydro-
pyrazolo[3,4-d]pyrimidin-6-one (4g)
IR (KBr): 3361, 3200, 2982, 1661, 1570, 1452, 790 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.21 (s, 3H, CH3-3), 5.44 (s,
1H, CH-4), 6.85–7.12 (m, 5H, Ar–H), 7.37 (d, 2H,
J= 8.1 Hz, ArH), 7.57 (d, 2H, J= 8.1 Hz, ArH), 8.16
(s,1H, NH-5), 9.24 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 11.6, 43.6, 105.3, 118.3, 126.3,
126.8, 127.4, 128.2, 128.5, 128.9, 139.5, 142.2, 149.2, 150.8,
166.4 ppm; MS (ESI): m/z 350 (M+ H)+. Anal. Calcd. for
C18H15N5O3 (%): C, 61.89; H, 4.30; N, 20.06. Found: C,
61.84; H, 4.25; N, 20.01.
2.4.8. 3-Methyl-1-phenyl-4-(4-nitrophenyl)-1,4,5,7-tetrahydro-
pyrazolo[3,4-d]pyrimidin-6-thione (4h)
IR (KBr): 3358, 3203, 2973, 1574, 1369, 1254, 772 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.19 (s, 3H, CH3-3), 5.47 (s,
1H, CH-4), 6.94–7.06 (m, 5H, Ar–H), 7.33 (d, 2H,
J= 8.2 Hz, ArH), 7.53 (d, 2H, J= 8.2 Hz, ArH), 8.20
(s,1H, NH-5), 9.21 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 12.1, 43.9, 105.4, 118.6, 126.2,
126.6, 127.6, 128.3, 128.5, 129.2, 139.4, 143.0, 149.1, 150.7,
167.2 ppm; MS (ESI): m/z 366 (M+ H)+. Anal. Calcd. for
C18H15N5O2S (%): C, 59.18; H, 4.11; N, 15.34. Found: C,
59.11; H, 4.10; N, 15.25.
2.4.9. 3-Methyl-1-phenyl-4-(4-bromophenyl)-1,4,5,7-
tetrahydro-pyrazolo[3,4-d]pyrimidin-6-one (4i)
IR (KBr): 3355, 3199, 2974, 1671, 1568, 1454, 792 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.26 (s, 3H, CH3-3), 5.40 (s,
1H, CH-4), 6.93–7.05 (m, 5H, Ar–H), 7.36 (d, 2H,
J= 8.1 Hz, ArH), 7.52 (d, 2H, J= 8.1 Hz, ArH), 8.16
(s,1H, NH-5), 9.24 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 12.0, 44.2, 105.0, 118.7, 126.4,
126.7, 127.5, 128.3, 128.6, 128.9, 138.9, 143.0, 148.8, 151.1,
166.8 ppm; MS (ESI): m/z 383.5 (M+ H)+. Anal. Calcd. for
C18H15BrN4O (%): C, 56.41; H, 3.92; N, 14.62. Found: C,
56.33; H, 3.90; N, 14.57.
2.4.10. 3-Methyl-1-phenyl-4-(4-bromophenyl)-1,4,5,7-
tetrahydro-pyrazolo[3,4-d]pyrimidin-6-thione (4j)
IR (KBr): 3357, 3195, 2973, 1565, 1368, 1251, 776 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.23 (s, 3H, CH3-3), 5.43 (s,
1H, CH-4), 6.80–7.02 (m, 5H, Ar–H), 7.27 (d, 2H,
J= 8.2 Hz, ArH), 7.51 (d, 2H, J= 8.2 Hz, ArH), 8.12
(s,1H, NH-5), 9.19 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 12.4, 44.4, 104.8, 117.9, 126.1,
126.7 127.4, 128.4, 128.7, 129.4, 138.9, 142.6, 149.1, 150.5,
166.7 ppm; MS (ESI): m/z 399.7 (M+ H)+. Anal. Calcd. for
C18H15BrN4S (%): C, 54.15; H, 3.76; N, 14.00. Found: C,
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IR (KBr): 3352, 3198, 2975, 1673, 1574, 1449, 785 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.17 (s, 3H, CH3-3), 5.54 (s,
1H, CH-4), 6.95–7.12 (m, 5H, Ar–H), 7.31–7.53 (m, 4H, Ar–
H), 8.11 (s, 1H, NH-5), 9.21 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 11.5, 44.3, 105.3, 118.3, 126.3,
126.5, 127.7, 128.5, 128.7, 129.3, 139.3, 142.7, 149.1, 150.4,
166.6 ppm; MS (ESI): m/z 350 (M+ H)+. Anal. Calcd. for
C18H15N5O3 (%): C, 61.89; H, 4.30; N, 20.06. Found: C,
61.77; H, 4.31; N, 20.00.
2.4.12. 3-Methyl-1-phenyl-4-(3-nitrophenyl)-1,4,5,7-
tetrahydro-pyrazolo[3,4-d]pyrimidin-6-thione (4l)
IR (KBr): 3363, 3211, 2977, 1570, 1370, 1247, 778 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.19 (s, 3H, CH3-3), 5.46 (s,
1H, CH-4), 6.89–7.09 (m, 5H, Ar–H), 7.39–7.58 (m, 4H, Ar–
H), 8.18 (s, 1H, NH-5), 9.23 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 11.9, 44.2, 105.4, 118.7, 126.2,
126.4, 127.3, 128.2, 128.6, 128.9, 139.5, 143.1, 148.9, 150.7,
166.4 ppm; MS (ESI): m/z 366 (M+ H)+. Anal. Calcd. for
C18H15N5O2S (%): C, 59.18; H, 4.11; N, 15.34. Found: C,
59.11; H, 4.03; N, 15.31.
2.4.13. 3-Methyl-1-phenyl-4-(3-bromophenyl)-1,4,5,7-
tetrahydro-pyrazolo[3,4-d]pyrimidin-6-one (4m)
IR (KBr): 3358, 3211, 2981, 1669, 1576, 1446, 779 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.22 (s, 3H, CH3-3), 5.44 (s,
1H, CH-4), 6.91–7.08 (m, 5H, Ar–H), 7.40–7.57 (m, 4H, Ar–
H), 8.15 (s, 1H, NH-5), 9.19 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 11.8, 43.8, 105.5, 118.5, 126.4,
126.8, 127.4, 128.4, 128.8, 129.4, 139.6, 143.1, 149.0, 151.2,
167.2 ppm; MS (ESI): m/z 383.5 (M+ H)+. Anal. Calcd. for
C18H15BrN4O (%): C, 56.41; H, 3.92; N, 14.62. Found: C,
56.34; H, 3.90; N, 14.55.
2.4.14. 3-Methyl-1-phenyl-4-(3-bromophenyl)-1,4,5,7-
tetrahydro-pyrazolo[3,4-d]pyrimidin-6-thione (4n)
IR (KBr): 3349, 3197, 2972, 1573, 1367, 1254, 769 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.29 (s, 3H, CH3-3), 5.48 (s,
1H, CH-4), 6.92–7.10 (m, 5H, Ar–H), 7.32–7.54 (m, 4H, Ar–
H), 8.18 (s, 1H, NH-5), 9.26 (s, 1H, NH-7) ppm; 13C NMR
(125 MHz, DMSO-d6) d: 12.1, 43.7, 104.9, 118.2, 126.1,
126.6, 127.7, 128.3, 128.6, 129.5, 139.4, 142.8, 149.3, 151.3,
166.6 ppm; MS (ESI): m/z 399.5 (M+ H)+. Anal. Calcd. for
C18H15BrN4S (%): C, 54.15; H, 3.76; N, 14.00. Found: C,
54.13; H, 3.78; N, 13.88.
2.4.15. 3-Methyl-1-phenyl-4-(4-methylphenyl)-1,4,5,7-
tetrahydro-pyrazolo[3,4-d]pyrimidin-6-one (4o)
IR (KBr): 3353, 3213, 2984, 1668, 1573, 1443, 773 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.10 (s, 3H, CH3), 2.19 (s,
3H, CH3-3), 5.43 (s, 1H, CH-4), 6.89–7.15 (m, 5H, Ar–H),
7.34 (d, 2H, J= 8.4 Hz, ArH), 7.55 (d, 2H, J= 8.4 Hz,
ArH), 8.11 (s,1H, NH-5), 9.25 (s, 1H, NH-7) ppm; 13C
NMR (125 MHz, DMSO-d6) d: 12.7, 18.9, 43.9, 105.5, 118.7,
126.3, 126.8, 127.5, 128.4, 128.9, 129.5, 139.6, 142.6, 149.2,
150.7, 166.8 ppm; MS (ESI): m/z 319 (M+ H)+. Anal. Calcd.
for C19H18N4O (%): C, 71.70; H, 5.66; N, 17.61. Found: C,
71.63; H, 5.63; N, 17.57.limidazolium bromide: A green reaction media for the eﬃcient synthesis of 3-
g phthalimide-N-sulfonic acid as catalyst, Journal of Saudi Chemical Society
Table 1 Evaluation of catalytic activity of different catalysts
for the synthesis of 3-methyl-1,4-diphenyl-1,4,5,7-tetrahydro-
pyrazolo[3,4-d]pyrimidine-6-one in [Bmim][Br] at 80 C.a
Entry Catalyst mol% Time (h) Yield (%)b
1c PISA 10 5 14
2 PISA 10 1 94
3 InCl3 10 3 44
4 BiCl3 10 3 57
5 Sulfamic acid 10 2 71
6 p-TSA 10 2 76
7 Cu(OTf)2 10 3 51
a Reaction conditions: 1-phenyl-3-methyl-1H-pyrazole-5(4H)-one
(1 mmol), benzaldehyde (1 mmol), urea (1.2 mmol) at 80 C.
b Isolated yield.
c Without [Bmim][Br].
Ionic liquid 1-butyl-3-methylimidazolium bromide 52.4.16. 3-Methyl-1-phenyl-4-(4-methylphenyl)-1,4,5,7-
tetrahydro-pyrazolo[3,4-d]pyrimidin-6-thione (4p)
IR (KBr): 3355, 3199, 2975, 1576, 1365, 1245, 776 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.07 (s, 3H, CH3), 2.22 (s,
3H, CH3-3), 5.49 (s, 1H, CH-4), 6.80–7.10 (m, 5H, Ar–H),
7.25 (d, 2H, J= 8.4 Hz, ArH), 7.51 (d, 2H, J= 8.4 Hz,
ArH), 8.07 (s,1H, NH-5), 9.24 (s, 1H, NH-7) ppm; 13C
NMR (125 MHz, DMSO-d6) d: 12.4, 19.2, 43.4, 105.2, 118.4,
126.1, 126.6, 127.2, 128.2, 128.6, 129.1, 139.3, 142.3, 149.0,
150.3, 166.3 ppm; MS (ESI): m/z 335 (M+H)+. Anal. Calcd.
for C19H18N4S (%): C, 68.26; H, 5.39; N, 16.77. Found: C,
68.16; H, 5.31; N, 16.71.
2.4.17. 3-Methyl-1-phenyl-4-(4-methoxyphenyl)-1,4,5,7-
tetrahydro-pyrazolo[3,4-d]pyrimidin-6-one (4q)
IR (KBr): 3350, 3216, 2989, 1664, 1574, 1448, 779 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.21 (s, 3H, CH3-3), 3.67 (s,Table 2 Synthesis of 3-methyl-1,4-diphenyl-1,4,5,7-tetrahydro-pyraz
different reaction conditions.a
Entry Solvent PISA (mol%)
1 EtOH 10
2 DMF 10
3 CH3CN 10
4 CHCl3 10
5 1,4-Dioxane 10
6 [HNEt3][Ac] 10
7 [Bmim][Cl] 10
8 [Bmim]BF4 10
9 [Bmim]PF6 10
10 [Bmim][Br] 10
11 [Bmim][Br] 0
12 [Bmim][Br] 2
13 [Bmim][Br] 4
14 [Bmim][Br] 8
15 [Bmim][Br] 12
16 [Bmim][Br] 14
17 [Bmim][Br] 10
18 [Bmim][Br] 10
19 [Bmim][Br] 10
20 [Bmim][Br] 10
a Reaction conditions: 1-phenyl-3-methyl-1H-pyrazole-5(4H)-one (1 mm
b Isolated yield.
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(2016), http://dx.doi.org/10.1016/j.jscs.2016.07.0013H, OCH3), 5.40 (s, 1H, CH-4), 6.78–7.00 (m, 5H, Ar–H),
7.24 (d, 2H, J= 8.2 Hz, ArH), 7.45 (d, 2H, J= 8.2 Hz,
ArH), 8.10 (s,1H, NH-5), 9.17 (s, 1H, NH-7) ppm; 13C
NMR (125 MHz, DMSO-d6) d: 12.3, 44.3, 53.7, 104.5, 117.7,
126.0, 126.5 127.3, 128.3, 128.5, 129.3, 138.7, 142.4, 149.0,
150.1, 166.1 ppm; MS (ESI): m/z 335 (M+H)+. Anal. Calcd.
for C19H18N4O2 (%): C, 68.26; H, 5.39; N, 16.77. Found: C,
68.20; H, 5.36; N, 16.75.
2.4.18. 3-Methyl-1-phenyl-4-(4-methoxyphenyl)-1,4,5,7-
tetrahydro-pyrazolo[3,4-d]pyrimidin-6-thione (4r)
IR (KBr): 3358, 3198, 2977, 1572, 1360, 1247, 778 cm1; 1H
NMR (500 MHz, DMSO-d6): d 2.27 (s, 3H, CH3-3), 3.60 (s,
3H, OCH3), 5.49 (s, 1H, CH-4), 6.88–7.13 (m, 5H, Ar–H),
7.34 (d, 2H, J= 8.2 Hz, ArH), 7.57 (d, 2H, J= 8.2 Hz,
ArH), 8.17 (s,1H, NH-5), 9.22 (s, 1H, NH-7) ppm; 13C
NMR (125 MHz, DMSO-d6) d: 12.6, 44.7, 54.1, 104.7, 117.7,
126.4, 126.9 127.5, 128.5, 128.9, 129.7, 138.9, 142.9, 149.5,
150.7, 167.1 ppm; MS (ESI): m/z 351 (M+H)+. Anal. Calcd.
for C19H18N4OS (%): C, 65.14; H, 5.14; N, 16.00. Found: C,
65.07; H, 5.10; N, 16.02.
3. Results and discussion
To obtain the optimum conditions for the synthesis of 3-met
hyl-1,4-diphenyl-1,4,5,7-tetrahydro-pyrazolo[3,4-d]pyrimidine-
6-one, the reaction of 1-phenyl-3-methyl-1H-pyrazole-5(4H)-
one 1, benzaldehyde 2 and urea 3 was chosen as a model
reaction.
Initially, a systematic study was carried out for catalytic
evaluation of PISA for the preparation of 3-methyl-1,4-diphe-
nyl-1,4,5,7-tetrahydro-pyrazolo[3,4-d]pyrimidine-6-one at a
temperature of 80 C (Table 1). Our studies showed that in
the presence of PISA under solvent-free conditions, the yield
of the final product was not high, mainly because the reactionolo[3,4-d]pyrimidine-6-one in the presence of PISA as catalyst in
Temperature (C) Time (h) Yield (%)b
Reflux 5.0 59
Reflux 5.0 43
Reflux 7.0 36
Reflux 5.0 42
Reflux 4.0 44
80 2.0 82
80 2.0 78
80 2.0 80
80 2.0 77
80 1.0 94
80 7.0 -
80 1.8 41
80 1.5 64
80 1.2 80
80 1.0 93
80 1.0 93
50 2.5 51
60 2.0 66
70 1.5 79
90 1.0 93
ol), benzaldehyde (1 mmol) and urea (1.2 mmol).
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Table 3 Synthesis of various 3-methyl-1,4-diphenyl-1,4,5,7-tetrahydro-pyrazolo [3,4-d]pyrimidine-6-one/thiones in [Bmim][Br] in the
presence of PISA (10 mol%).a
Entry Aldehyde Urea/thiourea Product Time (h) Yield (%)b
1 CHO
NH2
NH2O
HN
NH
N
N
O
CH3
4a
1.0 94
2 CHO
NH2
NH2S
HN
NH
N
N
S
CH3
4b
1.0 91
3
Cl
CHO
NH2
NH2O
HN
NH
N
N
O
CH3
4c
Cl
0.8 95
4
Cl
CHO
NH2
NH2S
HN
NH
N
N
S
CH3
4d
Cl
0.8 92
5
F
CHO
NH2
NH2O
HN
NH
N
N
O
CH3
4e
F
0.8 95
6
F
CHO
NH2
NH2S
HN
NH
N
N
S
CH3
4f
F
0.8 93
7
NO2
CHO
NH2
NH2O
HN
NH
N
N
O
CH3
4g
NO2
0.8 92
8
NO2
CHO
NH2
NH2S
HN
NH
N
N
S
CH3
4h
NO2
0.8 90
9
Br
CHO
NH2
NH2O
HN
NH
N
N
O
CH3
4i
Br
0.8 94
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Table 3 (continued)
Entry Aldehyde Urea/thiourea Product Time (h) Yield (%)b
10
Br
CHO
NH2
NH2S
HN
NH
N
N
S
CH3
4j
Br
0.8 91
11 CHO
NO2 NH2
NH2O
HN
NH
N
N
O
CH3
4k NO2
1.0 90
12 CHO
NO2 NH2
NH2S
HN
NH
N
N
S
CH3
4l NO2
1.0 90
13 CHO
Br NH2
NH2O
HN
NH
N
N
O
CH3
4m Br
1.0 93
14 CHO
Br NH2
NH2S
HN
NH
N
N
S
CH3
4n Br
1.0 90
15
CHO
CH3 NH2
NH2O
HN
NH
N
N
O
CH3
4o
CH3
1.2 87
16
CHO
CH3 NH2
NH2S
HN
NH
N
N
S
CH3
4p
CH3
1.2 86
17
CHO
OCH3 NH2
NH2O
HN
NH
N
N
O
CH3
4q
OCH3
1.2 87
18
CHO
OCH3 NH2
NH2S
HN
NH
N
N
S
CH3
4r
OCH3
1.2 86
a Reaction conditions: 1-phenyl-3-methyl-1H-pyrazole-5(4H)-one (1 mmol), benzaldehyde (1 mmol) and urea (1.2 mmol).
b Isolated yield.
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Figure 1 Recyclability of the catalyst: PISA catalyst could be
reused four times without any loss of its activity.
Scheme 3 Plausible mechanism for the formation of the 3-methyl-
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(2016), http://dx.doi.org/10.1016/j.jscs.2016.07.001mixture could not be stirred well. In order to improve the yield,
the ionic liquid [Bmim][Br] was used as solvent. The results
indicated that the reaction proceeded efficiently using PISA
in [Bmim][Br], and the desired product was obtained in excel-
lent yield (Table 1, entry 2). A comparison of catalytic activity
of Brønsted and Lewis acids was examined in the model reac-
tion under the optimal reaction conditions, showing the high-
est catalytic activity of PISA (Table 1, entries 3–7).
Screening of the reaction conditions was established suit-
able solvents, the temperature as well as the amount of catalyst
for the desired model reaction (Table 2). It was exciting that
the chosen solvents such as ethanol (EtOH), N,N-
dimethylformamide (DMF), acetonitrile (CH3CN), chloro-
form (CHCl3), 1,4-dioxane, [HNEt3][Ac], [Bmim][Cl], [Bmim]
BF4, [Bmim]PF6, [Bmim][Br], etc. were suitable for the model
reaction (Table 2, entries 1–10). Ionic liquid [Bmim][Br] proved
to be the best among them (Table 2, entry 10). It is noteworthy
that no reaction occurred in the absence of the catalyst even
after a long time (7 h, Table 2, entry 11). Lower yield was
obtained when the same reaction was carried out with lower
amount of the catalyst (Table 2, entries 12–14). Further, with1,4-diphenyl-1,4,5,7-tetrahydro-pyrazolo[3,4-d]pyrimidine-6-one.
limidazolium bromide: A green reaction media for the eﬃcient synthesis of 3-
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could be observed in the yield of the product (Table 2, entries
15–16). Lowering the temperature to 50 C, 60 C and 70 C,
decreased the conversion to 51%, 66% and 79% respectively
(Table 2, entries 17–19). Notably, higher temperature (90 C)
makes no obvious difference in the yield of the product
(Table 2, entry 20). Overall, we found that, in the presence
of 10 mol% of PISA in [Bmim][Br] at 80 C the product was
formed in excellent yield.
Thus, we selected the optimized reaction condition to exam-
ine the universality of this catalyst’s application with different
electron rich and deficient substrates. Various substituted aro-
matic aldehydes, 1-phenyl-3-methyl-1H-pyrazole-5(4H)-one,
and urea/thiourea undergo the reaction in the presence of cat-
alytic amount of PISA (10 mol%) in [Bmim][Br] at 80 C to
furnish the corresponding 3-methyl-1,4-diphenyl-1,4,5,7-tetra
hydro-pyrazolo[3,4-d]pyrimidine-6-one/thiones (Scheme 1).
The results of this study are summarized in Table 3. It was
indicated that both electron deficient and electron rich aro-
matic aldehydes worked well, giving high yields of the product
in shorter reaction time. The reusability of the catalyst is one
of the most important benefits and makes it useful for com-
mercial applications. Thus the recovery and reusability of
PISA were investigated. The PISA used for the transformation
was recovered and used for further reactions and gave good
yield for further reactions as shown in Fig. 1.
A plausible mechanism for the formation of products 4 is
shown in Scheme 3. Initially, with the aid of PISA in the pres-
ence of [Bmim][Br], intermediate 5 is formed through conden-
sation of 5-methyl-2-phenyl-2H-pyrazol-3-ol 1b and aromatic
aldehyde 2. Addition of urea/thiourea 3 to the intermediate 5
gives intermediate 6. Then, the intermediate 6 undergoes
heterocyclization and isomerization to furnish the correspond-
ing 3-methyl-1,4-diphenyl-1,4,5,7-tetrahydro-pyrazolo[3,4-d]
pyrimidine-6-one/thiones product 4 (Scheme 3).
4. Conclusions
In summary, we have developed a direct and efficient method
for the preparation of 3-methyl-1,4-diphenyl-1,4,5,7-tetrahy
dro-pyrazolo[3,4-d]pyrimidine-6-one/thiones using catalytic
amount of phthalimide-N-sulfonic acid (PISA) in 1-butyl-3-
methylimidazolium bromide ionic liquid. The simplicity of
the procedure, eco-friendly, non-volatile, and easy handling
are the advantages of these methods. These methods not only
afford the products in excellent yields but also avoid the prob-
lems associated with pollution.
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